The panel deciding who ages slower hasn't written its own rules

The review panel convened at the Meridian Longevity Institute this morning to answer a question it has, so far, declined to put in writing: what is a person's renewal value, and who gets to grade it. Nobody has offered so much as a working draft.

The metric under review would move an applicant up the coastal cohort waitlist — forty thousand names deep, crawling forward at 1.9 percent last quarter — in exchange for a signed pledge to vacate public office. Strip the language and what's on the table is simple: the therapy that slows aging, dangled in front of anyone willing to give up a chair. Submissions opened this morning and stay open through the next transfer window. The old waitlist keeps moving on its old logic while the new one gets argued over down the hall.

"We are being asked to price a resignation," said one panelist, who declined to be named ahead of formal testimony. "There is no clinical instrument for that. We measure kidney function. We do not measure whether a judge deserves another century."

The first witnesses came from the cohort that has waited longest — not for the therapy, but for the offices sitting on top of it. A woman who clerked at the Charter Court described a decade of stalled succession lines, chairs that were supposed to turn over and simply didn't. She spoke for eleven minutes and named no one. The omission did the naming for her. Justice Aurelio Vance, 130 years old, has held his bench for 130 years and turned down retirement for the third time this month. The sit-in outside his chambers in Concord is in its fifth week: thirty-one occupiers at any given hour, roughly ninety rotating through six-hour shifts.

The ethicists who testified cared less about Vance than about the lever itself. Trade therapy for office once, the argument went, and you've built a mechanism that can be pointed at any vacancy someone powerful happens to want filled. A metric that renews an institution in the morning can purge a dissenter by afternoon, and the rubric won't know the difference — there isn't one yet. That's the part the chart keeps circling back to. The proposal scores renewal value on criteria nobody has published. The board is being asked to ratify a formula it hasn't seen.

The Institute's own senior counsel has warned, in writing, that conditioning therapy on resignation may violate the Accord's equal-access clause — the one that says, roughly, that a place in a medical line can't be bought with anything but need.

The board that governs the coastal list has eleven members. Seven have already received tier-one therapy. None has disclosed a placement on any waitlist. None will be scored on renewal value, either; the metric, whatever shape it eventually takes, is being drafted by people who already got old on their own terms. (It is, medically speaking, a remarkable coincidence how often the cure arrives just in time for the people writing the prescription.)

Submissions close at the transfer window. The rubric stays unpublished.